The following Abs were used: mouse anti-cytokeratin-3/2p monoclonal antibody (mAb; AE-5, 1:100; Santa Cruz Biotechnology, Inc, Dallas, TX, USA), mouse anti-human cytokeratin-4 mAb (6B10, 1:300; Abcam, Cambridge, UK), rabbit monoclonal [EP1599Y] anti-human cytokeratin 4 (1:200, Abcam), mouse anti-human cytokeratin-7 mAb (RCK105, 1:10000; Millipore, Billerica, MA, USA), mouse anti-human cytokeratin-13 mAb (1:20; American Research Products, Inc., Palos Verdes, CA, USA), mouse anti-human cytokeratin-12 mAb (N-16; 1:500; Santa Cruz Biotechnology), rabbit anti-cytokeratin 12/K12 mAb (1:200, EPR17882, Abcam), rabbit anti-human MUC5AC polyclonal Ab (H-160, 1:100, Santa Cruz Biotechnology), anti-FGFR1 mAb (1:200, 133105; R&D Systems, Minneapolis, MN, USA), anti-human FGFR2 (blocking) mAb (1:200, 98725; R&D Systems), anti-FGFR3 mAb (1:200, 135334; R&D Systems), anti-FGFR4 mAb (1:200, 137114; R&D Systems), and anti-FGFR1 blocking mAb (VBS1; Chemicon, Temecula, CA, USA). As a control, mouse immunoglobulin G (IgG; Sigma-Aldrich), mouse immunoglobulin M (IgM; Sigma-Aldrich) or normal rabbit serum (Agilent Technology, Tokyo, Japan) was used instead of the primary Ab. The secondary Abs used were fluorescence-labeled goat anti-mouse IgG (Alexa Fluor 488, 1:200; Thermo Fisher Scientific), fluorescence-labeled goat anti-rabbit IgG (Alexa Fluor 594, 1:400; Thermo Fisher Scientific), donkey anti-mouse IgG (H+L) highly cross-adsorbed secondary antibody (Alexa Fluor 488, 1:500, Thermo Fisher Scientific), and donkey anti-rabbit IgG (H+L) highly cross-adsorbed secondary antibody (Alexa Fluor 647, 1:500, Thermo Fisher Scientific).